The goal of this program is to provide nurses with an overview of the new-drug approval process and the potential nursing roles in stroke clinical trials for investigational drugs. After studying the information presented here, you will be able to —
- Describe the phases of clinical trials for U.S. Food and Drug Administration (FDA) approval of new drugs.
- Explain the multiple roles of nurses who care for patients during stroke clinical trials.
- List both typical adverse effects of drugs under investigation for strokes and complications of strokes.
